In 1994 universal iodization of salt was introduced on the whole Bulgarian territory. In 2005, аn international expert group gave the country credit for solving the problem of iodine deficiency. The last screening of pregnant Bulgarian women in 2019 confirmed the presence of iodine sufficiency among the population. The current study aimed at updating the data on the prevalence of thyroid dysfunction (hypothyroidism and hyperthyroidism) in the country under conditions of iodine sufficiency in the Bulgarian population. The last population screening was conducted 12 years ago, allowing us to make a comparison with the current one in 2024, as both screenings were carried out under the conditions of systematic and continuous universal iodization of salt across the entire territory of Bulgaria. Material and Methods: 936 subjects were distributed into three age groups: 20-44 years - 342 (36.5%), 45-59 years - 301 (32.2%) and 60-79 years - 293 (31.3%). TSH (ECLIA-sandwich method), FT4 (competitive ECLIA method), TPOAb (ECLIA-method of the Cobas e601 analyzer) were examined. Thyroid dysfunction, which includes subclinical and clinical forms, was analysed regarding the frequency of each type and form in the studied population, as well as its distribution according to gender and among the three age groups. The data gathered in 2012 and 2024 were compared. Results: Hypothyroidism is the dominant disorder - 14.4% (135/936), while hyperthyroidism is 1.81% (17/936), p < 0.05. The highest number of patients have subclinical hypothyroidism - 13.67% (128/936). The prevalence of increased TPO antibodies is 14.4% (133/936) and as expected, it is more common in women - 71.4% (95/133) compared to men - 28.6% (38/133), p < 0.001. The current thyroid dysfunction in our country has significantly increased - from 6.91% (166/2402) in 2012 to 16.23% (152/936) in 2024, p < 0.01. The relative share of known diagnosed cases during this 12-year period shows a marked rise - from 44.51% (73/164) to 63.16% (96/152) - p < 0.02 > 0.01, while the relative share of newly diagnosed cases during screening has a significant drop - from 55.49% (91/164) to 36.84% (56/152) - p < 0.02. Conclusion: These favorable trends in the reduction of undiagnosed cases of thyroid dysfunction are the result of increased diagnosis of thyroid pathology, ongoing regular screening campaigns, and raised awareness among the population, which is proof of the medical community beneficial work in the country.
Published in | Clinical Medicine Research (Volume 14, Issue 3) |
DOI | 10.11648/j.cmr.20251403.14 |
Page(s) | 65-79 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Hypothyroidism, Hyperthyroidism, Diagnosed, Undiagnosed, Trends
[1] | Taylor, Peter N., Albrecht, Diana, Scholz, Anna, Gutierrez-Buey, Gala, Lazarus, John H., Dayan, Colin M. and Okosieme, Onyebuchi E. 2018. Global epidemiology of hyperthyroidism and hypothyroidism. Nature Reviews Endocrinology 14 (5), pp. 301-316. |
[2] | Reyes Domingo F, Avey MT, Doull M. Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: A systematic review. Syst Rev 2019; 8(1): 260. |
[3] | Ittermann, T., Khattak, R. M., Nauck, M., Cordova, C. M. & Volzke, H. Shift of the TSH reference range with improved iodine supply in Northeast Germany. Eur J Endocrinol 2015, 172, 261-267. |
[4] | Garmendia Madariaga A, Santos Palacios S, GuillénGrima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014; 99(3): 923-31. |
[5] | Garduno Garcia JDJ, Chavez AO and El´ıas-Lo´ pez D (2023). Subclinical thyroid disease: present knowledge and future direction, volume II. Front. Endocrinol. 14: 1293910. |
[6] | Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep; 390 (10101): 1550-62. |
[7] | Peeters RP. Subclinical Hypothyroidism. N Engl J Med. 2017 Oct; 377(14): 1404. |
[8] | Peter N Taylor, Marco M Medici, Alicja Hubalewska-Dydejczyk, Kristien Boelaert. Hypothyroidism. Seminar Volume 404, Issue 10460, p1347-1364, October 05, 2024. |
[9] | Zimmermann, M. B. Iodine deficiency. Endocr Rev 2009, 30, 376-408. |
[10] | Dasgupta, P. K., Liu, Y. & Dyke, J. V. Iodine nutrition: iodine content of iodized salt in the United States. Environmental science & technology 42, 1315-1323 (2008). |
[11] | Iodine Global Network in 2016 Annual report IGN: Seattle, WA. 22 May, 2016. |
[12] | Decree of the Council of Ministers 96/1994 on the introduction of universal iodization of salt in Bulgaria, State newspaper 43 of 1994. |
[13] | Review of Progress towards Sustained Optimal Iodine Nutrition in Bulgaria. Report by a team of experts on behalf of the Network for Sustained Elimination of Iodine Deficiency, ed by Tz. Timcheva, SMART Publ. 2006. pp 32. |
[14] | UNICEF, State of the World’s Children. (2017). Global Experience of with salt iodization: percentage of households currently cosuming iodized salt. ISBN: 978-92-806-5003-7. |
[15] | Anna-Maria Borissovа, Ludmila Ivanova, Boyana Trifonova, Lilia Dakovska, Eugenia Mihailova, Mircho Vukov. Role of Supplementations of Combined Vitamins with Minerals on Iodine Status in Pregnant Women in Bulgaria. International Journal of Diabetes and Endocrinology 2020; 5(3): 47-53. |
[16] | World Health Organization (2004). Iodine status worldwide: WHO global database on iodine deficiency. Geneva. ISBN 92 4 159200 1. |
[17] | WHO, UNICEF, KDIGO (2001). Assessment of iodine deficiency disorders and monitoring their elimination. A guide for programme managers, 2nd ed. WHO, Geneva. ISBN 978 92 4 159582 7. |
[18] | Akinbami LJ, Chen TC, Davy O, Ogden CL, Fink S, Clark J. et al. National Health and Nutrition Examination Survey, 2017-March 2020 Prepandemic File: Sample Design, Estimation and Analytic Guidelines. Data Evaluation and Methods Research. NATIONAL CENTER FOR HEALTH STATISTICS. Vital and Health Statistic Series 2, Number 190 May 2022. |
[19] |
NSI. National population census in Bulgaria. National Statistical Institute. December 2022.
https://www.nsi.bg/sites/default/files/files/publications/StatBook_Census2021.pdf |
[20] | 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). Authors/Task Force Members: Giuseppe Mancia (Chairperson), Reinhold Kreutz (Co-Chair), Mattias Brunstrom, Michel Burnierd, Guido Grassie, Andrzej Januszewiczf et al. J. of Hypertension. 2023; Vol 41, Number 12. |
[21] | Diogo Mendes, Carlos Alves, Nuno Silverio, Francisco Batel Marques. Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis. Eur Thyroid J. 2019 May 17; 8(3): 130-143. |
[22] | Gussekloo, J. et al. Thyroid status, disability and cognitive function, and survival in old age. Jama 292, 2591-2599 (2004). |
[23] | Ludwig U, Holzner D, Denzer C, Greinert A, Haenle MM, Oeztuerk S. et al. EMIL-Study Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. BMC Endocr Disord. 2015 Aug; 15(1): 41. |
[24] | Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 2008 Aug; 33(7): 1013-22. |
[25] | Biondi B, Cooper DS. Subclinical Hyperthyroidism. N Engl J Med. 2018; 378(25): 2411-2419. |
[26] | Peeters RP. Subclinical Hypothyroidism. N Engl J Med. 2017; 376 (26): 2556-2565. |
[27] | Zimmermann MB, Hess S. Y, Molinari L, de Benoist B, Delange F, Braverman L. E, Fujieda K, Ito Y, Jooste P. L, Moos K, Jooste P. L, Pearce E. N Pretell E. A, Shishiba Y. (2004). New reference values for thyroid volume by ultrasound in iodine sufficient school children: a World Health Organization / Nutrition for Health and Development Iodine Deficiency Study Group Report. Am J Clin Nutr 79: 231-237. |
[28] | Masooma Naseem, Sajjad Ali, Sara Qadir, Anshahrah Riaz, Abdullah Monawwer, Burhanuddin Tahir, Zehra Naseem and Zahid Mehmood. Trends of Pathological Findings in Patients with Thyroid Diseases: A Single-center, Retrospective Study. Clinical Medicine Insights: Endocrinology and Diabetes 2024, Volume 17: 1-7. |
[29] | Sharafi M, Baeradeh N, Daliri M, Kargar H, Haghjoo E, Farhadi A, Afrashteh S. Investigating the Prevalence of Thyroid Disorders and Their Contributing Factors in Iran: A Cross-Sectional Analysis. J Health Sci Surveillance Sys. 2024; 12(3): 344-350). |
[30] | Nermin Diab, Natalie R. Daya, Stephen P. Juraschek, Seth S. Martin, John W. Mcevoy, Ulla T. Schultheiß, Anna Köttgen, Elizabeth Selvin. Prevalence and Risk factors of thyroid Dysfunction in older Adults in the community. Scientific RepoRtS (2019) 9: 13156. |
[31] | Wouters, H. J. C. M., Slagter, S. N., Muller Kobold, A. C., van der Klauw, M. M., & Wolffenbuttel, B. H. R. (2020). Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands PLoS ONE, 15(11), 1-17. Article 0242795. |
[32] | Awad SAS, Ashraf EM, Khaled AS. et al. The epidemiology of thyroid diseases in the Arab world: A systematic review. J Public Health Epidemiol 2016; 8(2): 17-26. |
[33] | Shiva Kargar, Seyed Mehdi Tabatabaei, Hassan Okati-Aliabad and Hossein Izadi Rad. Prevalence of Thyroid Dysfunction Disorders among Adult Populations in the Middle-East: A Systematic Review and Meta-analysis. Open Public Health J, 2024; 17: e18749445317174. |
[34] |
Shinkov A, Borissova AM, Vlahov J, Dakovska L, Blajeva E. Male gender differences in the thyroid ultrasound features, thyroid peroxidase antibodies and thyroid hormone levels: a large population-based study. J Endocrinol Invest. 2014 Mar; 37(3): 269-76.
https://doi.org/10.1007/s40618-013-0024-y Epub 2014 Jan 9. |
[35] | Ivana Striki´c Ðula, Nikolina Plei´c, Mirjana Babi´c Leko, Ivana Gunjaˇca, Vesela Torlak, Dubravka Brdar, Ante Punda, Ozren Polašek, Caroline Hayward and Tatijana Zemunik. Epidemiology of Hypothyroidism, Hyperthyroidism and Positive Thyroid Antibodies in the Croatian Population. Biology 2022, 11, 394. |
[36] | Kamel M. Ajlouni, Nahla Khawaja, Mohammed EL‑Khateeb, Anwar Batieha and Oraib Farahid. The prevalence of thyroid dysfunction in Jordan: a national population-based survey. BMC Endocrine Disorders (2022) 22: 253. |
[37] | Alexander Shinkov, Anna-Maria Borissova, Roussanka Kovatcheva, Jordan Vlahov, Lilia Dakovska, Iliana Atanassova, Mirtcho Vukov, Nina Aslanova. Thyroid dysfunction and cardiovascular risk factors in Bulgarian adults. Cent. Eur. J. Med. 8(6) 2013, 742-748. |
[38] | Arulmani Thiyagarajan, Niklas Koenen, Till Ittermann, Henry Völzke, Ulrike Haug. Trends in the use of thyroid diagnostics and treatments between 2008 and 2019 in Germany. Scientific Reports (2024) 14: 26710. |
[39] | Line Tang Møllehave, Allan Linneberg, Tea Skaaby, Nils Knudsen, Torben Jørgensen, Betina Heinsbæk Thuesen. Trends in treatments of thyroid disease following iodine fortification in Denmark: a nationwide registerbased study. Clin. Epidemiol. 2018, 10, 763-770. |
[40] | Gonzalo J Acosta, Naykky Singh Ospina, Juan P Brito. Epidemiologic changes in thyroid disease. Curr Opin Endocrinol Diabetes Obes 2024 Oct 1; 31(5): 184-190. |
[41] | Massa’d HBR. National survey to assess iodine deficiency disorders (IDD) among Jordanian children—2010. Amman: World Health Organization Non‑Communicable Disease Department, Jordan Ministry of Health Nutrition Department; 2011. UNICEF Jordan Country Office The Hashemite Kingdom of Jordan WFP Jordan Country Office. |
APA Style
Borissova, A., Trifonova, B., Dakovska, L., Vukov, M. (2025). Characteristics and Dynamics of Thyroid Dysfunction in the Bulgarian Population - Screening 2024. Clinical Medicine Research, 14(3), 65-79. https://doi.org/10.11648/j.cmr.20251403.14
ACS Style
Borissova, A.; Trifonova, B.; Dakovska, L.; Vukov, M. Characteristics and Dynamics of Thyroid Dysfunction in the Bulgarian Population - Screening 2024. Clin. Med. Res. 2025, 14(3), 65-79. doi: 10.11648/j.cmr.20251403.14
@article{10.11648/j.cmr.20251403.14, author = {Anna-Maria Borissova and Boyana Trifonova and Lilia Dakovska and Mircho Vukov}, title = {Characteristics and Dynamics of Thyroid Dysfunction in the Bulgarian Population - Screening 2024 }, journal = {Clinical Medicine Research}, volume = {14}, number = {3}, pages = {65-79}, doi = {10.11648/j.cmr.20251403.14}, url = {https://doi.org/10.11648/j.cmr.20251403.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20251403.14}, abstract = {In 1994 universal iodization of salt was introduced on the whole Bulgarian territory. In 2005, аn international expert group gave the country credit for solving the problem of iodine deficiency. The last screening of pregnant Bulgarian women in 2019 confirmed the presence of iodine sufficiency among the population. The current study aimed at updating the data on the prevalence of thyroid dysfunction (hypothyroidism and hyperthyroidism) in the country under conditions of iodine sufficiency in the Bulgarian population. The last population screening was conducted 12 years ago, allowing us to make a comparison with the current one in 2024, as both screenings were carried out under the conditions of systematic and continuous universal iodization of salt across the entire territory of Bulgaria. Material and Methods: 936 subjects were distributed into three age groups: 20-44 years - 342 (36.5%), 45-59 years - 301 (32.2%) and 60-79 years - 293 (31.3%). TSH (ECLIA-sandwich method), FT4 (competitive ECLIA method), TPOAb (ECLIA-method of the Cobas e601 analyzer) were examined. Thyroid dysfunction, which includes subclinical and clinical forms, was analysed regarding the frequency of each type and form in the studied population, as well as its distribution according to gender and among the three age groups. The data gathered in 2012 and 2024 were compared. Results: Hypothyroidism is the dominant disorder - 14.4% (135/936), while hyperthyroidism is 1.81% (17/936), p 0.01, while the relative share of newly diagnosed cases during screening has a significant drop - from 55.49% (91/164) to 36.84% (56/152) - p Conclusion: These favorable trends in the reduction of undiagnosed cases of thyroid dysfunction are the result of increased diagnosis of thyroid pathology, ongoing regular screening campaigns, and raised awareness among the population, which is proof of the medical community beneficial work in the country. }, year = {2025} }
TY - JOUR T1 - Characteristics and Dynamics of Thyroid Dysfunction in the Bulgarian Population - Screening 2024 AU - Anna-Maria Borissova AU - Boyana Trifonova AU - Lilia Dakovska AU - Mircho Vukov Y1 - 2025/06/12 PY - 2025 N1 - https://doi.org/10.11648/j.cmr.20251403.14 DO - 10.11648/j.cmr.20251403.14 T2 - Clinical Medicine Research JF - Clinical Medicine Research JO - Clinical Medicine Research SP - 65 EP - 79 PB - Science Publishing Group SN - 2326-9057 UR - https://doi.org/10.11648/j.cmr.20251403.14 AB - In 1994 universal iodization of salt was introduced on the whole Bulgarian territory. In 2005, аn international expert group gave the country credit for solving the problem of iodine deficiency. The last screening of pregnant Bulgarian women in 2019 confirmed the presence of iodine sufficiency among the population. The current study aimed at updating the data on the prevalence of thyroid dysfunction (hypothyroidism and hyperthyroidism) in the country under conditions of iodine sufficiency in the Bulgarian population. The last population screening was conducted 12 years ago, allowing us to make a comparison with the current one in 2024, as both screenings were carried out under the conditions of systematic and continuous universal iodization of salt across the entire territory of Bulgaria. Material and Methods: 936 subjects were distributed into three age groups: 20-44 years - 342 (36.5%), 45-59 years - 301 (32.2%) and 60-79 years - 293 (31.3%). TSH (ECLIA-sandwich method), FT4 (competitive ECLIA method), TPOAb (ECLIA-method of the Cobas e601 analyzer) were examined. Thyroid dysfunction, which includes subclinical and clinical forms, was analysed regarding the frequency of each type and form in the studied population, as well as its distribution according to gender and among the three age groups. The data gathered in 2012 and 2024 were compared. Results: Hypothyroidism is the dominant disorder - 14.4% (135/936), while hyperthyroidism is 1.81% (17/936), p 0.01, while the relative share of newly diagnosed cases during screening has a significant drop - from 55.49% (91/164) to 36.84% (56/152) - p Conclusion: These favorable trends in the reduction of undiagnosed cases of thyroid dysfunction are the result of increased diagnosis of thyroid pathology, ongoing regular screening campaigns, and raised awareness among the population, which is proof of the medical community beneficial work in the country. VL - 14 IS - 3 ER -